Mechanical and Pharmacological Revascularization Strategies for Prevention of Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction: Analysis from Index of Microcirculatory Resistance Registry Data

Table 3

Clinical outcomes for 3-year MACE in study population.

Parameter	Total (N = 153)	High IMR (N = 52)	Low IMR (N = 101)	value
3-years MACE, n (%)	17 (11.1%)	8 (15.4%)	9 (8.9%)	0.279
CV death	3 (2.0%)	3 (5.8%)	0 (0.0%)	0.038
Hospitalization for HF	1 (0.7%)	1 (1.9%)	0 (0.0%)	0.340
TLR	7 (4.6%)	1 (1.9%)	6 (5.9%)	0.424
Stent thrombosis	3 (2.0%)	1 (1.9%)	2 (2.0%)	1.000
Nonfatal MI	0 (0.0%)	0 (0.0%)	0 (0.0%)	1.000
Stroke	3 (2.0%)	2 (3.8%)	1 (1.0%)	0.267
Major bleeding	2 (1.3%)	2 (3.8%)	0 (0.0%)	0.114

CV, cardiovascular; HF, heart failure; IMR, index of microcirculatory resistance; MACE, major advanced cardiac events; MI, myocardial infarction; TLR, target lesion revascularization. MACE was defined as composite of CV death, hospitalization because of HF, TLR, stent thrombosis, nonfatal MI, stroke, and major bleeding.